Synergistic effects of interferon γ and tumour necrosis factor α on T84 cell function

Gut

Volumn 45, Issue 2, 1999, Pages 191-198

  Fish, S M ^a   Proujansky, R ^a,b   Reenstra, W W ^a,b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Apoptosis; Cystic fibrosis transmembrane conductance regulator; Inflammatory bowel disease; Ion secretion; TNF receptor expression; Transepithelial resistance

Indexed keywords

CALCIUM; CYCLIC AMP; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GAMMA INTERFERON; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL MEMBRANE RESISTANCE; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; RECEPTOR GENE; SHORT CIRCUIT CURRENT;

EID: 0032854183     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.2.191     Document Type: Article

References (36)

1. Breese E, Braegger CP, Corrigan CJ, et al. Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993;78:127-31.
2. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reverse transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-35.
3. Woywodt A, Neustock P, Kruse A, et al. Cytokine expression in intestinal mucosal biopsies. In situ hybridization of mRNA for interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease. European Cytokine Network 1994;5:387-95
4. MacDonald TT, Hutchings P, Choy M-Y, et al. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301-5.
5. Stack WA, Mann SD, Roy AJ, et al. Randomized controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease. Lancet 1997;349:521-4.
6. Van Dullemen HM, Van Deventer SJH, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
7. Dharmsathaphorn K, McRoberts JA, Mandel KG, et al. A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol 1984;246:G204-8.
8. Reenstra WW. cAMP- and Ca-dependent Cl secretion by phorbol esters: inhibition of basolateral K′ channels. Am J Physiol 1993;264:C161-8.
9. Adams RB, Planchon SM, Roche JK. INF-γ-modulation of epithelial barrier function: time course, reversibility, and site of cytokine binding. J Immunol 1993;150:2356-63.
10. Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-7.
11. Colgan SP, Parkos CA, Matthews JB, et al. Interferon-γ induces a cell surface phenotype switch on T84 intestinal epithelial cells. Am J Physiol 1994;267:C402-10.
12. Besançon F, Przewlocki G, Baro I, et al. Interferon-γ down-regulates CFTR gene expression in epithelial cells. Am J Physiol 1994;267:C1398-404.
13. Colgan SP, Resnick MB, Parkos CA, et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994;153:2122-9.
14. McKay DD, Croitoru K, Perdue MH. T cell-monocyte interactions regulate epithelial physiology in a coculture model of inflammation. Am J Physiol 1996;270:C418-28.
15. Eckmann L, Jung HC, Schürer-Maly C, et al. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993;105:1689-97.
16. Jung HC, Eckmann L, Yang S-K, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95:55-65.
17. Lin Y, Kirby JA, Browell DA, et al. Renal allograft rejection: expression and function of VCAM-1 on tubular epithelial cells. Clin Exp Immunol 1993;92:145-51.
18. Wu AJ, Kurrasch RH, Katz J, et al. Effect of tumor necrosis factor-α and interferon-γ on the growth of a human salivary gland cell line. J Cell Physiol 1994;161:217-26.
19. Ruggiero V, Tavernier J, Fiers W, et al. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J Immunol 1986;136:2445-50.
20. Taylor CT, Dzus AL, Colgan SP. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor α. Gastroenterology 1998;114:657-88.
21. Sanders SE, Madara JL, McGuirk DK, et al. Assessment of inflammatory events in epithelial permeability: a rapid screening method using fluorescein dextrans. Epithelial Cell Biol 1995;4:25-34.
22. Gregory RJ, Cheng SH, Rich DP, et al. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 1990;347:382-6.
23. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983;64:313-20.
24. Sellins KS, Cohen JJ. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987;139:3199-206.
25. Abreu-Martin MT, Vidrich A, Lynch DH, et al. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of fas antigen. J Immunol 1995;155:4147-54.
26. Kogan SC, Doherty M, Gitschier J. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. N Eng J Med 1987;317:985-90.
27. Gray PW, Barrett KJ, Chantry D, et al. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Pro Natl Acad Sci USA 1990;87:7380-4.
28. Kohno T, Brewer MT, Baker SL, et al. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 1990;87:8331-5.
29. Kuhnert P, Kemper O, Wallach D. Cloning, sequencing and partial functional characterization of the 5′ region of the human p75 tumor necrosis factor receptor-encoding gene (TNF-R). Gene 1994;150:381-6
30. Ho ML, Molnar G, Funanage VL, et al. Myogenic factor expression and quantitation in satellite cells derived from growing rat skeletal muscle. Basic and Applied Myology 1996;6:145-55.
31. Bazzoni F, Beutler B. The tumour necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
32. Vandenabeele P, Declercq W, Beyaert R, et al. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995;5:392-9.
33. Bebo BF Jr, Linthicum DS. Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects on interleukin-1β, interferon-γ and TNF-α on cultured cells. J Neuroimmunol 1995;62:161-7.
34. Carrel S, Hartmann F, Salvi S, et al. Expression of type A and B tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN-γ. Int J Cancer 1995;62:76-83.
35. Ossina NK, Cannas A, Powers VC, et al. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997;272:16351-7.
36. Yonehara S, Ishii AI, Yonehara M. A cell-killing monoclonal antibody (anti-fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-56.